IN2003DE02242A - Lipoteichoic acid from latic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria - Google Patents
Lipoteichoic acid from latic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteriaInfo
- Publication number
- IN2003DE02242A IN2003DE02242A IN2242DE2003A IN2003DE02242A IN 2003DE02242 A IN2003DE02242 A IN 2003DE02242A IN 2242DE2003 A IN2242DE2003 A IN 2242DE2003A IN 2003DE02242 A IN2003DE02242 A IN 2003DE02242A
- Authority
- IN
- India
- Prior art keywords
- bacteria
- gram
- immune responses
- acid
- lipoteichoic
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title abstract 6
- 239000002253 acid Substances 0.000 title abstract 5
- 230000028993 immune response Effects 0.000 title abstract 3
- 241000192125 Firmicutes Species 0.000 title abstract 2
- 230000001404 mediated effect Effects 0.000 title abstract 2
- 230000001717 pathogenic effect Effects 0.000 title abstract 2
- 229920000126 latex Polymers 0.000 title 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 6
- 235000014655 lactic acid Nutrition 0.000 abstract 3
- 239000004310 lactic acid Substances 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 2
- 208000034309 Bacterial disease carrier Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 229940023486 oral product Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 229940025703 topical product Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/739—Lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01201958A EP1260227A1 (en) | 2001-05-23 | 2001-05-23 | Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2003DE02242A true IN2003DE02242A (en) | 2006-01-20 |
Family
ID=8180365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2242DE2003 IN2003DE02242A (en) | 2001-05-23 | 2003-12-23 | Lipoteichoic acid from latic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US20040147010A1 (xx) |
| EP (2) | EP1260227A1 (xx) |
| JP (1) | JP4738717B2 (xx) |
| KR (1) | KR20040018375A (xx) |
| CN (1) | CN100502888C (xx) |
| AT (1) | ATE394111T1 (xx) |
| AU (1) | AU2002338873B8 (xx) |
| BR (1) | BR0209975A (xx) |
| CA (1) | CA2449403C (xx) |
| DE (1) | DE60226436D1 (xx) |
| DK (1) | DK1395269T3 (xx) |
| ES (1) | ES2305256T3 (xx) |
| IN (1) | IN2003DE02242A (xx) |
| MX (1) | MX260807B (xx) |
| NO (1) | NO20035187L (xx) |
| PL (1) | PL366455A1 (xx) |
| PT (1) | PT1395269E (xx) |
| RU (1) | RU2320356C2 (xx) |
| SG (1) | SG101083A1 (xx) |
| WO (1) | WO2002094296A1 (xx) |
| ZA (1) | ZA200309821B (xx) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2408573A (en) * | 2003-11-25 | 2005-06-01 | Univ Leicester | Assay for the interaction of L-Ficolin with lipoteichoic acid |
| US20050238631A1 (en) * | 2003-12-04 | 2005-10-27 | Steve Burwell | Methods and compositions for preventing biofilm formation, reducing existing biofilms, and for reducing populations of bacteria |
| US7709032B2 (en) | 2003-12-05 | 2010-05-04 | Toyo R&D Inc. | Anti-allergic agent containing both ground lotus and/or extract and lactic acid bacterium |
| US20050158294A1 (en) | 2003-12-19 | 2005-07-21 | The Procter & Gamble Company | Canine probiotic Bifidobacteria pseudolongum |
| US8877178B2 (en) | 2003-12-19 | 2014-11-04 | The Iams Company | Methods of use of probiotic bifidobacteria for companion animals |
| WO2005091933A2 (en) * | 2004-03-04 | 2005-10-06 | E-L Management Corporation | Skin treatment method with lactobacillus extract |
| US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
| JP4726109B2 (ja) * | 2005-02-10 | 2011-07-20 | 昭和電工株式会社 | 皮膚外用剤、それを用いる皮膚有害微生物の付着予防方法及び増殖防止方法 |
| US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
| AU2006253006B8 (en) | 2005-05-31 | 2011-09-15 | Alimentary Health Ltd | Feline probiotic Lactobacilli |
| AU2006253007B2 (en) | 2005-05-31 | 2012-12-20 | Alimentary Health Ltd | Feline probiotic Bifidobacteria |
| MX2009008166A (es) | 2007-02-01 | 2009-08-12 | Iams Company | Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate. |
| US8920814B2 (en) * | 2007-03-08 | 2014-12-30 | The Governors Of The University Of Alberta | Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| WO2008134450A2 (en) * | 2007-04-24 | 2008-11-06 | Kemin Industries, Inc. | Broad-spectrum antibacterial and antifungal activity of lactobacillus johnsonii d115 |
| JP5225652B2 (ja) * | 2007-10-29 | 2013-07-03 | 雪印メグミルク株式会社 | アディポネクチン分泌促進及び／又は減少抑制剤 |
| US9771199B2 (en) | 2008-07-07 | 2017-09-26 | Mars, Incorporated | Probiotic supplement, process for making, and packaging |
| EP2140772A1 (en) * | 2008-07-03 | 2010-01-06 | Nestec S.A. | Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract |
| US9232813B2 (en) * | 2008-07-07 | 2016-01-12 | The Iams Company | Probiotic supplement, process for making, and packaging |
| SG171930A1 (en) * | 2008-12-16 | 2011-07-28 | Nestec Sa | Compositions and methods for improved oral health |
| US8784798B2 (en) * | 2009-05-11 | 2014-07-22 | Nestec S.A. | Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders |
| US10104903B2 (en) | 2009-07-31 | 2018-10-23 | Mars, Incorporated | Animal food and its appearance |
| US20120190634A1 (en) * | 2009-08-26 | 2012-07-26 | Rna Inc. | Lipoteichoic acid-derived glycolipids, and compositions comprising same |
| WO2012118535A1 (en) | 2011-03-01 | 2012-09-07 | Quorum Innovations, Llc | Materials and methods for treating conditions associated with pathogenic biofilm |
| CA2828612A1 (en) * | 2011-03-03 | 2012-09-07 | The Governors Of The University Of Alberta | Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns |
| GB201112091D0 (en) * | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| US20130089638A1 (en) * | 2011-10-11 | 2013-04-11 | Mead Johnson Nutrition Company | Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes |
| EP2589387A1 (en) * | 2011-11-04 | 2013-05-08 | Lunamed AG | Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain |
| CN102399733B (zh) * | 2011-12-14 | 2014-07-09 | 北京大北农科技集团股份有限公司 | 约氏乳杆菌及其菌剂、应用和预混料 |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| US9399048B2 (en) * | 2014-03-05 | 2016-07-26 | Asian Probiotics And Prebiotics Ltd | Lactic acid bacteria and its applications in immunomodulation and anti-inflammation |
| CN104161775A (zh) * | 2014-05-29 | 2014-11-26 | 浙江大学宁波理工学院 | 来自丁酸梭菌的脂磷壁酸在调节水产动物免疫应答中的用途 |
| CN104161776A (zh) * | 2014-05-29 | 2014-11-26 | 浙江大学宁波理工学院 | 来自丁酸梭菌的脂磷壁酸及其调节畜禽免疫应答的用途 |
| BR112017012299B1 (pt) | 2014-12-23 | 2022-04-12 | 4D Pharma Research Limited | Bacterioide thetaiotaomicron, seu uso, composição, suplemento nutricional, gênero alimentício, produto alimentar, suplemento dietético ou aditivo alimentar e processo para produção destes |
| WO2016102951A1 (en) | 2014-12-23 | 2016-06-30 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
| EP3256004A1 (en) | 2015-02-13 | 2017-12-20 | Mars, Incorporated | Pet food feeding system |
| SG10201912323VA (en) | 2015-06-15 | 2020-02-27 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| HUE058252T2 (hu) | 2015-06-15 | 2022-07-28 | 4D Pharma Res Ltd | Baktériumtörzseket tartalmazó készítmények |
| SI3307288T1 (sl) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Spojine, ki vsebujejo bakterijske seve |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| MA41013A (fr) | 2015-11-20 | 2017-08-30 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
| GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
| PL3313423T3 (pl) | 2016-03-04 | 2019-09-30 | 4D Pharma Plc | Kompozycje zawierające szczepy bakteryjne blautia do leczenia nadwrażliwości trzewnej |
| JP2019510036A (ja) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物 |
| CA3018865A1 (en) | 2016-03-31 | 2017-10-05 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
| TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商４Ｄ製藥有限公司 | 包含細菌菌株之組合物 |
| CN106236826A (zh) * | 2016-08-12 | 2016-12-21 | 福建万亿店中店电子商务有限责任公司 | 一种用于阴道疾病辅助治疗的乳酸菌磷壁酸凝胶 |
| AU2017365019A1 (en) | 2016-11-23 | 2019-07-11 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
| GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
| TW201907928A (zh) | 2017-05-22 | 2019-03-01 | 英商4D製藥研究有限公司 | 包含細菌品系之組成物 |
| TW201907931A (zh) | 2017-05-24 | 2019-03-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組合物 |
| MA49373B1 (fr) | 2017-06-14 | 2021-02-26 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| KR102519483B1 (ko) | 2017-06-14 | 2023-04-10 | 4디 파마 리서치 리미티드 | 메가스파에라 (megasphera) 속의 세균 균주를 포함하는 조성물 및 이들의 용도 |
| KR102205829B1 (ko) * | 2017-06-14 | 2021-01-21 | 기초과학연구원 | 신규한 비피도박테리움 비피덤 균주 및 균주 유래 다당체 |
| ES2855701T3 (es) | 2017-06-14 | 2021-09-24 | 4D Pharma Res Ltd | Composiciones que comprenden cepas bacterianas |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| CN111053789A (zh) * | 2019-11-26 | 2020-04-24 | 湖南营养树生物科技有限公司 | 调节免疫系统的方法和组合物 |
| AU2020412749A1 (en) * | 2019-12-27 | 2022-06-16 | Biopolis, S.L. | Uses of lipoteichoic acid from Bifidobacteria |
| KR102325947B1 (ko) * | 2020-02-05 | 2021-11-15 | 주식회사 에이치이엠파마 | 신규한 락토바실러스 사케이 hem224 균주, 및 상기 균주 또는 이의 배양물을 포함하는 염증 또는 천식의 치료용 조성물 |
| CN116075317A (zh) * | 2020-06-26 | 2023-05-05 | 齐沃生物科学股份有限公司 | 通过施用天然免疫调节剂来加速/增强免疫反应的免疫引发 |
| JP2023179810A (ja) * | 2020-11-13 | 2023-12-20 | 味の素株式会社 | ラクトコッカス・ラクチス、ラクトバチルス属に属する微生物、又はこれらの混合微生物を含有する生菌剤及びその製造方法 |
| JP2023128590A (ja) * | 2022-03-03 | 2023-09-14 | 株式会社アルソア慧央グループ | 腸管免疫賦活剤、ＩｇＡ産生促進剤及び遺伝子発現促進剤 |
| CN115068510A (zh) * | 2022-05-24 | 2022-09-20 | 宁波大学 | 一种乳杆菌脂磷壁酸的提取方法及其抗炎活性应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4678773A (en) | 1983-08-26 | 1987-07-07 | Chugai Seiyaku Kabushiki Kaisha | Antitumor agent |
| JPS6048928A (ja) * | 1983-08-26 | 1985-03-16 | Chugai Pharmaceut Co Ltd | Ｔνｆ誘起剤 |
| JPS6048929A (ja) * | 1983-08-26 | 1985-03-16 | Chugai Pharmaceut Co Ltd | 抗腫瘍剤 |
| JPS61275217A (ja) * | 1985-05-29 | 1986-12-05 | Yakult Honsha Co Ltd | グラム陰性桿菌感染症防御剤 |
| US5804179A (en) * | 1985-12-31 | 1998-09-08 | Research Corporation Technologies, Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
| DE3817762A1 (de) * | 1988-05-26 | 1989-11-30 | Sanum Kehlbeck Gmbh & Co Kg | Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben |
| ES2111625T3 (es) * | 1992-07-06 | 1998-03-16 | Nestle Sa | Agente antigastritis. |
| AU6362594A (en) * | 1993-03-10 | 1994-09-26 | Miles Inc. | Hyaluronic acid used as a cancer treatment |
| US6180100B1 (en) * | 1994-09-30 | 2001-01-30 | Urex Biotech., Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
| JP3489930B2 (ja) * | 1996-03-08 | 2004-01-26 | 株式会社ヤクルト本社 | がん予防食品 |
| ES2243965T3 (es) * | 1996-07-09 | 2005-12-01 | Societe Des Produits Nestle S.A. | Procedimiento de secado mediante pulverizacion. |
| DE29724816U1 (de) * | 1997-01-09 | 2004-07-22 | Société des Produits Nestlé S.A. | Probiotik enthaltendes Getreideprodukt |
| US5998482A (en) * | 1997-11-10 | 1999-12-07 | David; Sunil A. | Use of synthetic polycationic amphiphilic substances with fatty acid or hydrocarbon substituents as anti-sepsis agents |
| JP3046303B1 (ja) * | 1999-06-24 | 2000-05-29 | 明治乳業株式会社 | Ｈｅｌｉｃｏｂａｃｔｅｒｐｙｌｏｒｉ除菌性飲食品 |
| DE19963420A1 (de) * | 1999-12-28 | 2001-07-12 | Sebo Gmbh | Gewinnung von biologischen Komponenten aus Körperflüssigkeiten |
-
2001
- 2001-05-23 EP EP01201958A patent/EP1260227A1/en not_active Withdrawn
-
2002
- 2002-04-23 PT PT02742909T patent/PT1395269E/pt unknown
- 2002-04-23 DK DK02742909T patent/DK1395269T3/da active
- 2002-04-23 AU AU2002338873A patent/AU2002338873B8/en not_active Ceased
- 2002-04-23 EP EP02742909A patent/EP1395269B1/en not_active Expired - Lifetime
- 2002-04-23 KR KR20037015185A patent/KR20040018375A/ko not_active Application Discontinuation
- 2002-04-23 CN CNB02810479XA patent/CN100502888C/zh not_active Expired - Fee Related
- 2002-04-23 US US10/478,079 patent/US20040147010A1/en not_active Abandoned
- 2002-04-23 MX MXPA03010598 patent/MX260807B/es active IP Right Grant
- 2002-04-23 PL PL02366455A patent/PL366455A1/xx not_active IP Right Cessation
- 2002-04-23 JP JP2002591013A patent/JP4738717B2/ja not_active Expired - Fee Related
- 2002-04-23 SG SG200306895A patent/SG101083A1/en unknown
- 2002-04-23 RU RU2003136828/15A patent/RU2320356C2/ru not_active IP Right Cessation
- 2002-04-23 WO PCT/EP2002/004436 patent/WO2002094296A1/en active IP Right Grant
- 2002-04-23 AT AT02742909T patent/ATE394111T1/de active
- 2002-04-23 BR BR0209975-6A patent/BR0209975A/pt not_active Application Discontinuation
- 2002-04-23 ES ES02742909T patent/ES2305256T3/es not_active Expired - Lifetime
- 2002-04-23 DE DE60226436T patent/DE60226436D1/de not_active Expired - Lifetime
- 2002-04-23 CA CA2449403A patent/CA2449403C/en not_active Expired - Fee Related
-
2003
- 2003-11-21 NO NO20035187A patent/NO20035187L/no not_active Application Discontinuation
- 2003-12-18 ZA ZA200309821A patent/ZA200309821B/xx unknown
- 2003-12-23 IN IN2242DE2003 patent/IN2003DE02242A/xx unknown
-
2008
- 2008-10-07 US US12/246,991 patent/US8329190B2/en not_active Expired - Fee Related
-
2013
- 2013-08-15 US US13/967,936 patent/US20140056927A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT1395269E (pt) | 2008-06-16 |
| CA2449403A1 (en) | 2002-11-28 |
| ES2305256T3 (es) | 2008-11-01 |
| SG101083A1 (en) | 2006-02-28 |
| ATE394111T1 (de) | 2008-05-15 |
| US20090142375A1 (en) | 2009-06-04 |
| US8329190B2 (en) | 2012-12-11 |
| MXPA03010598A (es) | 2004-03-09 |
| RU2320356C2 (ru) | 2008-03-27 |
| RU2003136828A (ru) | 2005-03-10 |
| EP1395269A1 (en) | 2004-03-10 |
| CA2449403C (en) | 2011-11-15 |
| NO20035187D0 (no) | 2003-11-21 |
| EP1260227A1 (en) | 2002-11-27 |
| JP4738717B2 (ja) | 2011-08-03 |
| JP2005500267A (ja) | 2005-01-06 |
| CN1525863A (zh) | 2004-09-01 |
| ZA200309821B (en) | 2005-03-18 |
| KR20040018375A (ko) | 2004-03-03 |
| EP1395269B1 (en) | 2008-05-07 |
| AU2002338873B2 (en) | 2008-04-10 |
| US20140056927A1 (en) | 2014-02-27 |
| MX260807B (es) | 2008-09-25 |
| PL366455A1 (en) | 2005-02-07 |
| BR0209975A (pt) | 2004-04-06 |
| CN100502888C (zh) | 2009-06-24 |
| US20040147010A1 (en) | 2004-07-29 |
| WO2002094296A1 (en) | 2002-11-28 |
| AU2002338873A1 (en) | 2002-12-03 |
| NO20035187L (no) | 2004-01-05 |
| DK1395269T3 (da) | 2008-08-04 |
| DE60226436D1 (de) | 2008-06-19 |
| AU2002338873B8 (en) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2003DE02242A (en) | Lipoteichoic acid from latic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria | |
| HUP0202051A2 (hu) | Tejsavbaktérium-kombináció és használata fertőzések és gyulladásos folyamatok megelőzésében és/vagy kezelésében | |
| CA2688736C (en) | Novel compositions containing lysozyme and c-1/c-4 polysaccharides and use thereof in oral care, cosmetology and dermatology, contraception, urology and gynecology | |
| NO20030316L (no) | Virkning av forskjellige CHO eller blanding på fekale bifidobakterier hos mennesker | |
| BR0113861A (pt) | Derivados de ácidos 3-(heteroaril acetamido)-2-oxo-azetidina-1-sulfÈnicos como agentes antibacterianos | |
| JP2009514861A5 (xx) | ||
| HUP9904308A2 (hu) | A mupirocin alkalmazása a nasopharynxnak patogén organizmusokkal történő kolonizációjához társuló bakteriális fertőzések kezelésére szolgáló gyógyszerkészítmény előállítására | |
| Coenye et al. | Biofilms in skin infections: Propionibacterium acnes and acne vulgaris | |
| MY159377A (en) | Aqueous suspensions of ciclesonide for nebulisation | |
| ATE289805T1 (de) | Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren | |
| BRPI0413509A (pt) | uso de antibióticos de quinolona | |
| JP2010064961A (ja) | 口腔常在菌叢調整剤およびこれを用いた口腔常在菌叢調整方法 | |
| Gichki et al. | HEALING EFFECTS OF NATURAL HONEY ON ORAL MINOR APTHOUS ULCERS AMONG DENTAL PATIENTS IN QUETTA. | |
| DE602004017586D1 (de) | Medizinische zusammensetzung zur behandlung von infektionen mit arzneimittelresistentem staphylococcus aureus | |
| GB0114672D0 (en) | Pharmaceutical formulations and methods of medical treatment | |
| Belal | Relevance of bacterial normal flora in antimicrobial resistance and how to overcome this resistance | |
| de Cássia Oliveira et al. | Bacteriophage Isolation from Denture Biofilm | |
| Zhamakochyan et al. | Chronic tonsillitis. The role of probiotics in the completion of the inflammatory process. | |
| CN111479569A (zh) | 氯唑西林抑制/预防生物膜形成的用途 | |
| Sumida et al. | Effectiveness and clinical applications of a safe edible antimicrobial peptide produced by lactic acid bacteria | |
| Snowden | Bacterial biofilm formation and immune evasion mechanisms | |
| Notari et al. | Ciprofloxacin: a study of usage in pedal infections with case reports | |
| BRPI0504979B8 (pt) | composições farmacêuticas antibacterianas |